SCHEMBL2887046

SCHEMBL2887046

COc1cc(C(=O)Nc2ccccc2Br)ccc1OC(F)F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
POLB P06746 2/20 0.58
TDP1 Q9NUW8 1/20 0.58
PDE4D Q08499 4/20 0.57
CHEK1 O14757 1/20 0.56
PIM1 P11309 1/20 0.56
MAPK8 P45983 1/20 0.56
CLK4 Q9HAZ1 1/20 0.56
ALDH1A1 P00352 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.54
TP53 P04637 1/20 0.54
TSHR P16473 1/20 0.54
MAPK1 P28482 1/20 0.54
PDE4A P27815 2/20 0.53
PDE4B Q07343 2/20 0.53
PDE4C Q08493 2/20 0.53
HTT P42858 1/20 0.53
NPSR1 Q6W5P4 1/20 0.52
MEN1 O00255 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29824491 1.00 NPC1 (0.58) NPC1RAB9APOLBTDP1PDE4D
SCHEMBL2887760 0.87 NPC1 (0.59) NPC1RAB9APOLBTDP1PDE4D
SCHEMBL30084839 0.87 NPC1 (0.59) NPC1RAB9APOLBTDP1PDE4D
SCHEMBL30084834 0.80 POLB (0.81) NPC1RAB9APOLBTDP1PDE4D
SCHEMBL2887996 0.80 POLB (0.81) NPC1RAB9APOLBTDP1PDE4D
SCHEMBL11244161 0.79 PDE4D (0.81) NPC1RAB9APOLBPDE4DCHEK1
SCHEMBL7334985 0.78 PDE4D (0.77) PDE4DPDE4APDE4BPDE4C
SCHEMBL2887769 0.78 PDE4D (0.63) NPC1RAB9APOLBTDP1PDE4D
SCHEMBL2887510 0.78 PDE4D (0.69) NPC1RAB9APOLBTDP1PDE4D
SCHEMBL2887182 0.77 RAB9A (0.52) NPC1RAB9APOLBTDP1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021213455-A1 DRUG COMBINATION AND USE THEREOF 浙江养生堂天然药物研究所有限公司 (CN) 2021-10-28 WO disclosed
US-7776893-B2 Use of PDE4 inhibitors for the treatment of diabetes mellitus NYCOMED GMBH (DE) 2010-08-17 US disclosed
EP-0706513-B1 FLUOROALKOXY-SUBSTITUTED BENZAMIDES AND THEIR USE AS CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITORS BYK GULDEN LOMBERG CHEM FAB (DE) 2002-05-15 EP disclosed
US-5712298-A Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1998-01-27 US disclosed
EP-0706513-A1 FLUOROALKOXY-SUBSTITUTED BENZAMIDES AND THEIR USE AS CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITORS Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1996-04-17 EP disclosed
WO-1995001338-A1 FLUOROALKOXY-SUBSTITUTED BENZAMIDES AND THEIR USE AS CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITORS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1995-01-12 WO disclosed